3rd International Edition Endo – Dubai
Mohammed Bin Rashid University Of Medicine and Health SciencesDubai, UAE Visit the Venue to read more
3rd International Edition Endo is organized by International Society for Gynecologic Endoscopy (ISGE) and will be held during Feb 01 - 03, 2018 at Mohammed Bin Rashid University Of Medicine and Health Sciences, Dubai, United Arab Emirates. The target audience for this medical event is Gynecologists, Surgeons, Endocrinologists.
This Conference is quickly becoming a reference in minimally invasive gynecological surgery providing a forum of the highest standard for scientific, clinical and social exchange. Hands-on sessions will expose you to the main challenges faced during surgery and allow you to further improve your suturing skills.
This edition will give way to Dubai’s very first Surgical Video Marathon. Top surgeons will demonstrate full or partial procedures that will be relayed through real-time video feed and commented step-by-step on site. This is the best place for a surgeon to get the practical answers needed to enhance his daily practice.
Dr. Alessandra Graziottin, Italy.
Dr. Antoine Watrelot, France
Pr. Benoit Rabischong, France
Dr. Brice Rodriguez, U.K.
Dr. Filipa Osorio, Portugal
Dr. Grigoris Grimbizis, Greece
Dr. Helder Ferreira, Portugal
Dr. Jacques Hamou, France
Dr. Marco Puga, Chili
Dr. Paya Pasic, U.S.A
Pr. Paulo Ayrosa, Brazil
Pr. Philippe Koninckx, Belgium
Dr. Rudi Campo, Belgium
Pr. Shaleish Putambekar, India
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Hyatt Regency Dubai Creek Heights,
Dubai Healthcare City,
Dubai, Dubai, United Arab Emirates 5668,
+971 4 553 1234
Abstract submission deadline 2017-12-31
Endo Dubai 2018 is now accepting abstracts on Innovation & Best Practices in Minimally Invasive Surgery in gynecology.
Abstracts should be submitted online by December 31st 2017. Abstracts received after this date will not be accepted.
Please scroll to the bottom of this page to submit your abstract.
The Scientific Committee will review all abstracts submitted and notify submitters of acceptance or rejection on January 12th 2018. The best 10 abstracts will be presented as an oral presentation. All remaining accepted abstracts will be displayed during free communication sessions (when available) or on posters and available for viewing throughout the Congress.
All abstracts should be submitted in English.
Abstracts must be submitted in one of the following categories. If an abstract covers more than one category, the most relevant one should be selected.
Topic 1: Hysteroscopy
Topic 2: Hysterectomy
Topic 3: Adenomyosis
Topic 4: Oncology
Topic 5: Adnexal pathology
Topic 6: Endometriosis
Topic 7: Urogynecology
Topic 8: Complications
Topic 9: Surgical innovations
Topic 10: Myomectomy
Topic 11: Reproductive surgery
Topic 12: Vaginal surgery
Abstracts should have a maximum of 350 words including authors’ details.
Abstracts should be structured as follows:
Abstracts can include tables, graphs and images (up to 500kb).
Abbreviations can be used if standard or if spelled out at first use.
The inclusion of brand names is not allowed. The mentioning of compounds must follow the scientific standard for publications.
Abstracts that do not comply with these guidelines will not be reviewed by the Scientific Committee.
The Scientific Committee will evaluate the abstracts based on their scientific or clinical value,
relevance to Endo Dubai 2018, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, ethics, originality of work and overall impression.
The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) in the session and the time assigned by the Scientific Committee. The registration fee for the presenting author will not be waived.
Abstracts will only be included in the final program if the corresponding author has registered and paid the registration fee.
Abstract withdrawal will only be accepted if notified in writing no later than January 15th 2018.
Contact No.: +971 4 286 63 13
Contact No.: +971 4 286 63 13